findmyKOL

Robert Canby, MD

Basic profile

Clinical Cardiac Electrophysiology

ORCIDNone on fileNPI
RegionAustin, TX · South CentralSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Robert Canby is a Cardiology physician. OpenAlex indexes 82 publications with 2,741 citations (h-index 24).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
82publications

Distinct works indexed by OpenAlex.

2,741citations

Total citations across indexed works.

24h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
32companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

3000 N Ih 35
Suite 700
Austin, TX 787051804

Telephone

512-807-3150

Registry record last updated 10 Feb 2022.

View the NPPES registry record

Industry payments

32 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    62.3%
    Beta blocker36.4%
    Metoprolol Succinate47%Sotalol28%Carvedilol15%Metoprolol Tartrate10%
    Part D88 patients
    Antiarrhythmic19.8%
    Flecainide Acetate45%Amiodarone Hcl41%Multaq10%Dofetilide4%
    Part D<11 patients

    + 1 more class in this area

  • Blood & clotting

    37.7%
    Factor Xa inhibitor37.7%
    Eliquis72%Xarelto28%
    Part D113 patients
Where care is delivered (Part B)15.8% facility · 84.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”